Savoldo B - Search Results

1

Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes.

Muralidharan S, Hanley PJ, Liu E, Chakraborty R, Bollard C, Shpall E, Rooney C, Savoldo B, Rodgers J, Dotti G. Muralidharan S, et al. Among authors: savoldo b. J Immunol. 2011 Nov 15;187(10):5221-32. doi: 10.4049/jimmunol.1101585. Epub 2011 Oct 19. J Immunol. 2011. PMID: 22013128 Free PMC article.

2

The use of cytotoxic t cells for the prevention and treatment of epstein-barr virus induced lymphoma in transplant recipients.

Savoldo B, Heslop HE, Rooney CM. Savoldo B, et al. Leuk Lymphoma. 2000 Nov;39(5-6):455-64. doi: 10.3109/10428190009113376. Leuk Lymphoma. 2000. PMID: 11342329 Review.

3

Adenovector-induced expression of human-CD40-ligand (hCD40L) by multiple myeloma cells. A model for immunotherapy.

Dotti G, Savoldo B, Takahashi S, Goltsova T, Brown M, Rill D, Rooney C, Brenner M. Dotti G, et al. Among authors: savoldo b. Exp Hematol. 2001 Aug;29(8):952-61. doi: 10.1016/s0301-472x(01)00668-3. Exp Hematol. 2001. PMID: 11495701 Free article.

4

Generation of autologous Epstein-Barr virus-specific cytotoxic T cells for adoptive immunotherapy in solid organ transplant recipients.

Savoldo B, Goss J, Liu Z, Huls MH, Doster S, Gee AP, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. Transplantation. 2001 Sep 27;72(6):1078-86. doi: 10.1097/00007890-200109270-00017. Transplantation. 2001. PMID: 11579304

5

Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals.

Savoldo B, Cubbage ML, Durett AG, Goss J, Huls MH, Liu Z, Teresita L, Gee AP, Ling PD, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. J Immunol. 2002 Jan 15;168(2):909-18. doi: 10.4049/jimmunol.168.2.909. J Immunol. 2002. PMID: 11777989

6

Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the prevention and treatment of EBV-associated post-transplant lymphomas.

Liu Z, Savoldo B, Huls H, Lopez T, Gee A, Wilson J, Brenner MK, Heslop HE, Rooney CM. Liu Z, et al. Among authors: savoldo b. Recent Results Cancer Res. 2002;159:123-33. doi: 10.1007/978-3-642-56352-2_15. Recent Results Cancer Res. 2002. PMID: 11785836

7

Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells.

Dotti G, Savoldo B, Yotnda P, Rill D, Brenner MK. Dotti G, et al. Among authors: savoldo b. Blood. 2002 Jul 1;100(1):200-7. doi: 10.1182/blood.v100.1.200. Blood. 2002. PMID: 12070028 Free article.

8

Immunotherapy for post-transplant lymphoproliferative disease.

Straathof KC, Savoldo B, Heslop HE, Rooney CM. Straathof KC, et al. Among authors: savoldo b. Br J Haematol. 2002 Sep;118(3):728-40. doi: 10.1046/j.1365-2141.2002.03594.x. Br J Haematol. 2002. PMID: 12181039 Free article. Review. No abstract available.

9

Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection.

Savoldo B, Huls MH, Liu Z, Okamura T, Volk HD, Reinke P, Sabat R, Babel N, Jones JF, Webster-Cyriaque J, Gee AP, Brenner MK, Heslop HE, Rooney CM. Savoldo B, et al. Blood. 2002 Dec 1;100(12):4059-66. doi: 10.1182/blood-2002-01-0039. Epub 2002 Aug 1. Blood. 2002. PMID: 12393655 Free article. Clinical Trial.

10

Fiber-modified adenoviruses generate subgroup cross-reactive, adenovirus-specific cytotoxic T lymphocytes for therapeutic applications.

Leen AM, Sili U, Savoldo B, Jewell AM, Piedra PA, Brenner MK, Rooney CM. Leen AM, et al. Among authors: savoldo b. Blood. 2004 Feb 1;103(3):1011-9. doi: 10.1182/blood-2003-07-2449. Epub 2003 Oct 2. Blood. 2004. PMID: 14525768 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters